Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study

Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study

The β-thalassemias are a group of monogenic hereditary hematological disorders caused by deletions and/or mutations of the β-globin gene, leading to low or absent production of adult hemoglobin (HbA). For β-thalassemia, sirolimus has been under clinical consideration in two trials (NCT03877809 and N...

Full description

Bibliographic Details
Main Authors: Maria Rita Gamberini, Cristina Zuccato, Matteo Zurlo, Lucia Carmela Cosenza, Alessia Finotti, Roberto Gambari
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Hematology Reports
Subjects:
β-thalassemia
sirolimus
SARS-CoV-2
vaccine
immunity
Online Access:https://www.mdpi.com/2038-8330/15/3/44

Similar Items

Similar Items